Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum92897ArticlesСтатьиResearch ArticleKognitivnye narusheniya v praktike terapevta: zabolevaniya serdechno-sosudistoy sistemyКогнитивные нарушения в практике терапевта: заболевания сердечно-сосудистой системыLevinO. SЛевинО. С

Кафедра неврологии

РМАПО, Москва15022009112VOL 11, NO2 (2009)ТОМ 11, №2 (2009)556128122021Copyright ©; 2009, Consilium MedicumCopyright ©; 2009, ООО "Консилиум Медикум"2009Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/92897

Развитие современной цивилизации неизбежно сопряжено с увеличением продолжительности жизни, что столь неизбежно приводит и к увеличению доли пожилых людей в популяции («постарению населения»). Этот процесс представляет собой серьезный вызов для современной медицинской науки и практики, который еще не вполне осознан. Для пожилых людей характерна высокая частота ряда заболеваний, в том числе нарушений когнитивных функций. Проблема когнитивных нарушений в последние годы приобретает все более актуальное социальное звучание и становится одной из основных проблем текущего столетия – «болезнью века» или даже «эпидемией века»

Дамулин И.В. Легкие когнитивные нарушения. Сonsilium Medicum 2004; 2: 138–41.Захаров В.В., Локшина А.Б. Применение препарата проноран (пирибедил) при легких когнитивных расстройствах у пожилых больных с дисциркуляторной энцефалопатией. Неврол. журн. 2004; 2: 30–5.Захаров В.В., Яхно Н.Н. Синдром умеренных когнитивных расстройств в пожилом возрасте: диагностика и лечение. Рус. мед. журн 2004; 10: 573–6.Левин О.С. Дисциркуляторная энцефалопатия: современные представления о механизмах развития и лечении. Consilium Medicum 2007; 4: 72–9.Левин О.С., Голубева Л.В. Гетерогенность умеренного когнитивного расстройства: диагностические и терапевтические аспекты. Consilium Medicum 2006; 12: 106–10.Левин О.С., Юнищенко Н.А. Диагностика и лечение когнитивных нарушений при дисциркуляторной энцефалопатии. Consilium Medicum 2007; 8: 47–53.Левин О.С. Семь шагов в диагностике и лечении когнитивных нарушений. М., 2007.Штульман Д.Р., Левин О.С. Неврология. Справочник практического врача. М.: Медпресс - информ, 2008.Acanfora D, Trojano L, Iannuzzi G.L. et al. The brain in congestive heart failure. Arch Gerontol Geriatr 1996; 23: 247–56.Alexopoulos G. The depression - executive dysfunction syndrome of late life. Am J Geriatr Psychiat 2001; 9: 22–9.Applegate W.B., Pressels S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioural variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154–60.Birns J, Morris R, Donaldson N, Kalra L. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006; 24: 1907–14.Birns J, Kalra L. Cognitive function and hypertension. J Human Hypertension 2009; 23: 86–96.Cacciatore F, Abete P, Ferrara N et al. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998; 46: 1343–8.Dubois B, Albert M.L. Amnestic MCI or prodromal Alzheimer’s disease. Lancet Neurology 2004; 3: 246–8.Dufouil C, Chalmers C, Coskun O et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS (Perindopril Protection against Recurrent Stroke Study) magnetic resonance imaging substudy. Circulation 2005; 112: 1644–50.Forette F, Seux M.L., Staessen J.A. et al. Prevention of dementia in randomised double - blind placebo - controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 2046–52.Gauthier S, Touchon J. Subclassification of mild cognitive impairment in research and in clinical practice. Alzheimer’s Disease and Related Disorders Annual, 2004; 61–70.Georgiadis D, Sievert M, Cencetti S et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21: 407–13.Gorkin L, Norvell N.K., Rosen R.C. et al. Assessment of quality of life as observed from the baseline data of the studies of left ventricular dysfunction (SOLVD) trial quality of life substudy. Am J Cardiol 1993; 71: 1069–73.Jefferson A, Benjamin E. Cardiovascular disease, cognitive decline and dementia. Vascular cognitive impairment in clinical practice. Eds. L.Wahlung, T.Erkinjuntti, S.Gauthier. Cambridge 2009; 166–77.Lithell H, Hansson L, Skoog I et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double - blind intervention trial. J Hypertens 2003; 21: 875–86.Mc Guinness B, Todd S, Passmore A, Bullock R. Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. J Neurol Neurosurg Psychiat 2008; 79: 4–5.Nagaraja D, Jayaashree S. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiat 2001; 158: 1517–9.O’Brien J.T., Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurology 2003; 2: 89–98.Palmer K, Wang H-X, Backman L et al. Differential evolution of cognitive impairment in nondemented older persons. Am J Psychiat 2002; 159: 436–42.Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the older patients with hypertension. A substudy of the SCOPE trial. Neurology 2008; 70: 1858–66.Petersen R.C., Stevens J.C., Ganguli M et al. Mild cognitive impairment (an evidence - based review). Neurology 2001; 56: 1131–42.Prince M, Bird A.S., Blizard R.A., Mann A.H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council\'s trial of hypertension in older adults. Br Med J 1996; 312: 801–5.Pullicino P.M., Hart J. Cognitive Impairment in congestive heart failure. Neurology 2001; 57: 1945–6.Rockwood K, Wentzel C, Hachinscki V et al. Prevalence and outcomes of vascular cognitive impairment. Neurology 2000; 54: 447–51.Sacktor N, Gray S, Kawas C et al. Blood Pressure within an Intermediate Range May Reduce Memory. J Geriatr Psychiatry Neurol 1999; 12: 1–6.Saxby B.K., Harrington F, Wesnes K.A. et al. Candesartan and cognitive decline in Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double - blind, placebo controlled trial. Lancet Neurol 2008; 7: 683–9.Shi J, Yang S.H., Stubley L et al. Hypoperfusion induces overexpression of beta - amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853: 1–4.Sparks D.L., Scheff S.W., Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non - demented individuals with hypertension. J Neurol Sci 1995; 131: 162–9.Trojano L, Incalzi R.A., Acaforo D et al. Cognitive Impairment: a key feature of congestive heart failure in the elderly. J Neurol 2003; 250: 1456–63.Tzourio C, Anderson C, Chapman N et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Inter Med 2003; 163: 1069–75.Vogels R, Oosterman J, Harten B. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007; 24: 418–23.Waldstein S.R., Giggey P.P., Thayer J.F. et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 2005; 45: 374–9.